1522 堤維西本益比(PER)
| 年度/月份 | 本益比(倍) | 月收盤價 |
|---|
| 2026/05 | 28.46 | 34.15 |
| 2026/04 | 25.79 | 30.95 |
| 2026/03 | 26.21 | 31.45 |
| 2026/02 | 36.67 | 44.00 |
| 2026/01 | 41.08 | 49.30 |
| 2025/12 | 38.29 | 45.95 |
| 2025/11 | 40.67 | 48.80 |
| 2025/10 | 39.92 | 47.90 |
| 2025/09 | 35.04 | 42.05 |
| 2025/08 | 34.38 | 41.25 |
| 2025/07 | 9.86 | 40.80 |
| 2025/06 | 11.33 | 46.90 |
| 2025/05 | 11.32 | 46.85 |
| 2025/04 | 10.13 | 48.20 |
| 2025/03 | 11.37 | 54.10 |
| 2025/02 | 13.38 | 63.70 |
| 2025/01 | 11.13 | 64.10 |
| 2024/12 | 10.97 | 63.20 |
| 2024/11 | 11.25 | 64.80 |
| 2024/10 | 10.57 | 59.60 |
| 2024/09 | 11.19 | 63.10 |
| 2024/08 | 11.91 | 67.20 |
| 2024/07 | 14.05 | 65.60 |
| 2024/06 | 15.33 | 71.60 |
| 2024/05 | 13.66 | 63.80 |
| 2024/04 | 15.17 | 50.20 |
| 2024/03 | 16.31 | 54.00 |
| 2024/02 | 15.29 | 50.60 |
| 2024/01 | 13.40 | 39.40 |
| 2023/12 | 13.78 | 40.50 |
| 2023/11 | 13.49 | 39.65 |
| 2023/10 | 13.75 | 37.40 |
| 2023/09 | 16.03 | 43.60 |
| 2023/08 | 12.61 | 34.30 |
| 2023/07 | 12.41 | 33.25 |
| 2023/06 | 13.86 | 37.15 |
| 2023/05 | 10.91 | 29.25 |
| 2023/04 | 10.14 | 29.50 |
| 2023/03 | 10.31 | 30.00 |
| 2023/02 | 9.76 | 28.40 |
| 2023/01 | 9.74 | 27.95 |
| 2022/12 | 9.70 | 27.85 |
| 2022/11 | 10.44 | 29.95 |
| 2022/10 | 13.03 | 25.15 |
| 2022/09 | 13.58 | 26.20 |
| 2022/08 | 15.88 | 30.65 |
| 2022/07 | 25.32 | 31.65 |
| 2022/06 | 22.48 | 28.10 |
| 2022/05 | 21.92 | 27.40 |
| 2022/04 | 31.45 | 19.50 |
| 2022/03 | 30.08 | 18.65 |
| 2022/02 | 29.92 | 18.55 |
| 2022/01 | 30.49 | 18.60 |
| 2021/12 | 31.80 | 19.40 |
| 2021/11 | 31.23 | 19.05 |
| 2021/10 | 22.93 | 19.95 |
| 2021/09 | 22.93 | 19.95 |
| 2021/08 | 22.87 | 19.90 |
| 2021/07 | 24.44 | 21.75 |
| 2021/06 | 24.66 | 21.95 |
| 2021/05 | 24.27 | 21.60 |
| 2021/04 | 29.46 | 24.75 |
| 2021/03 | 27.86 | 23.40 |
| 2021/02 | 28.69 | 24.10 |
| 2021/01 | - | 22.90 |